Potential actionable targets in appendiceal cancer detected by immunohistochemistry fluorescent in situ hybridization and mutational analysis

摘要

BackgroundAppendiceal cancers are rare and consist of carcinoid, mucocele, pseudomyxoma peritonei (PMP), goblet cell carcinoma, lymphoma, and adenocarcinoma histologies. Current treatment involves surgical resection or debulking, but no standard exists for adjuvant chemotherapy or treatment for metastatic disease.